Regeneron Releases New Linvoseltamab Analysis As It Inches Toward ASH, Regulatory Filing

 
• By Alaric DeArment
  
Regeneron announced an analysis from the Phase I/II LINKER-MM1 trial of linvoseltamab • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer